Assessment of atrial overdrive pacing as a treatment for OSAHS. (A prospective, randomized crossover study)

S. E. Schiza, E. N. Simantirakis, S. I. Chrysostomakis, N. C. Klapsinos, P. E. Vardas, N. M. Siafakas (Heraklion, Greece)

Source: Annual Congress 2005 - Clinical aspects of OSA II
Session: Clinical aspects of OSA II
Session type: Thematic Poster Session
Number: 3627
Disease area: Respiratory critical care, Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. E. Schiza, E. N. Simantirakis, S. I. Chrysostomakis, N. C. Klapsinos, P. E. Vardas, N. M. Siafakas (Heraklion, Greece). Assessment of atrial overdrive pacing as a treatment for OSAHS. (A prospective, randomized crossover study). Eur Respir J 2005; 26: Suppl. 49, 3627

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluating flutter device and the active cycle of breathing technique in non-cystic bronchiectasis: The prospective randomised study
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN)
Source: Eur Respir J, 58 (5) 2101937; 10.1183/13993003.01937-2021
Year: 2021



Glycopyrronium does not affect QT interval in healthy subjects: A randomized, 3-period cross-over, placebo- and positive-controlled study
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013


Effects of continuous positive airway pressure therapy on left ventricular diastolic function: a randomised, sham-controlled clinical trial
Source: Eur Respir J, 51 (2) 1701774; 10.1183/13993003.01774-2017
Year: 2018



Quality of life in patients with COPD and nocturnal supplemental oxygen-therapy: a prospective, placebo-controlled cross-over trial
Source: Eur Respir J 2005; 26: Suppl. 49, 289s
Year: 2005

Reduced lung function and risk of atrial fibrillation in a prospective cohort study
Source: Eur Respir J 2002; 20: Suppl. 38, 401s
Year: 2002

A randomised, double-blind, crossover, placebo-controlled trial of a mandibular advancement device for the treatment of snoring and mild obstructive sleep apnoea-hypopnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002

Effect of breathing oxygen-enriched air on exercise performance in patients with pulmonary hypertension in heart failure with preserved ejection fraction. Randomized, placebo-controlled, cross-over trial.
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021



A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol
Source: ERJ Open Res, 5 (4) 00186-2019; 10.1183/23120541.00186-2019
Year: 2019



Effectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013


Effects of ghrelin on the dyspnea pattern in cachectic COPD: Exploratory analysis of a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013


Early diaphragm pacing to delay non-invasive ventilation in patients with amyotrophic lateral sclerosis (RespiStimALS): A multicenter, triple-blind, randomized controlled trial
Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2016



Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial
Source: Eur Respir J 2013; 42: 1244-1254
Year: 2013



Diaphragmatic breathing training in COPD patients: A randomized, controlled and blinded trial
Source: Annual Congress 2010 - Respiratory muscles and breathing: assessment and training
Year: 2010


LATE-BREAKING ABSTRACT: COPD-associated severe pulmonary hypertension (COPDPH): results of a 16-weeks prospective multicenter, double-blind, placebo-controlled randomized clinical trial (RCT) [SPHERIC-1 (http://clinicaltrials.gov/ct2/show/NCT01441934)] investigating the effect of sildenafil citrate (Sld) on pulmonary vascular resistance (PVR) and PaO2.
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Oxygen uptake during cycle ergometry with and without functional electrical stimulation in COPD patients: a randomised placebo-controlled cross-over trial
Source: International Congress 2017 – Exercise training and breathing exercises in chronic respiratory disease
Year: 2017




Mandibular advancement device versus continuous positive airway pressure for treatment of obstruvtive sleep apnea syndrome: a randomized crossover trial
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


A prospective, randomised, cross-over study comparing unattended home-based versus attended in-hospital polysomnography
Source: Annual Congress 2009 - Diagnostic aspects in obstructive sleep apnoea
Year: 2009


Acetazolamide administration following upper airway surgery for SDB. Preliminary results of a randomized, double-blind, placebo-controlled study
Source: Eur Respir J 2005; 26: Suppl. 49, 201s
Year: 2005

Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial
Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019
Year: 2020